FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
The goal of UroToday International is to accelerate the timely and widespread dissemination of new urological research findings, and ultimately to impact clinical outcomes. This objective is most probably similar to all academic publishers, however most others survive by selling subscription use to libraries around the globe where according to a recent article in The Economist, Elsevier, the largest publisher of journals with nearly 2000 titles reported an operating profit margin of 36% while other media has experienced great declines. At the UIJ we offer manuscript submission, peer review and publication free for the authors providing the research and are now charging an annual subscription fee for use of the journal to offset the publications costs. All researchers, reviewers, and the editorial board provide their services for free. I want to express my sincere gratitude to our reviewers and editorial board members who contribute their time and resources to support the goal of free access to publishing, allowing results of important clinical or basic research findings to be provided to over 40,000 individual readers of this journal. We will continue on our journey to establish a new model for publishing that is privately supported to establish a way for all clinicians and scientists, irrespective of age or affiliation, the opportunity to have peer-review of their manuscripts and the power to have them published upon peer approval.
In this issue we have four original studies the first, by Anderson et al, was designed to determine the feasibility and effectiveness of medical hypnosis and cognitive behavioral therapy (CBT) for pain relief, improvement of psychological status, and quality of life in men with chronic prostatitis, (CP) also known as chronic pelvic pain syndrome (CPPS). The authors conclude the CBT and self-hypnosis training for patients with CP/CPPS was feasible, resulted in decreased symptoms, and provided patient self-directed methods to improve sense of control, ability to cope, and dissociation from pain symptoms.
Nederostek and colleagues present a subanalysis of stratification by risk group, race, prostate volume, and neoadjuvant hormone therapy for prostate cancer treated with current, third-generation cryotherapy. The authors conclude that the short-term results from this retrospective analysis justify the continuing use of cryosurgery for the management of localized prostate cancer.
Galal and Fath El-Bab studied the safety and efficacy of one stage ureteroscopy for the treatment of bilaterial ureteric stones. They conclude that the one-stage procedure was safe and effective and reduced anesthesia exposure and potentially provides cost savings.
Al-Sayyad and colleagues present an evaluation of biomarkers to differentiate upper from lower urinary tract infections in children younger than 2 years of age. The differentiation between the upper and lower UTI has important clinical implications in children where UTI is the most common bacterial infection. They conclude that some biomarkers used alone or in combination, help to differentiate between upper and lower UTI and may make more aggressive testing unnecessary in the future. Larger prospective studies will be necessary to confirm this finding.
Also in this issue is a mini report presenting a novel bridge technique designed for a skilled urologist, to simplify the learning curve for the laparoendoscopic single-site (LESS) surgery that includes an incisional LESS (iLESS) approach. The purpose of this report is to describe the method for establishing single-site access using the GelPort and standard instruments in a teaching hospital, as a learning tool toward LESS surgery.
There are also a series of case reports presented providing insights into less common situations that present in urology.
Thank you for your continued support in providing publication-worthy manuscripts - and to our reviewers and editorial board, a special recognition for your contributions in making timely decisions and recommendations.